Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
152M
-
Number of holders
-
549
-
Total 13F shares, excl. options
-
159M
-
Shares change
-
-1.87M
-
Total reported value, excl. options
-
$8.16B
-
Value change
-
-$122M
-
Put/Call ratio
-
0.36
-
Number of buys
-
295
-
Number of sells
-
-292
-
Price
-
$51.45
Significant Holders of BIO-TECHNE Corp - COMMON STOCK (TECH) as of Q2 2025
661 filings reported holding TECH - BIO-TECHNE Corp - COMMON STOCK as of Q2 2025.
BIO-TECHNE Corp - COMMON STOCK (TECH) has 549 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 159M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (18.4M shares), BlackRock, Inc. (12.2M shares), PRICE T ROWE ASSOCIATES INC /MD/ (8.85M shares), MORGAN STANLEY (6.58M shares), STATE STREET CORP (5.86M shares), GEODE CAPITAL MANAGEMENT, LLC (4.06M shares), Invesco Ltd. (3.66M shares), AMERIPRISE FINANCIAL INC (3.44M shares), Select Equity Group, L.P. (2.92M shares), and BAMCO INC /NY/ (2.8M shares).
This table shows the top 549 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.